IDVYNSO is approved for adults with virologically suppressed HIV-1 with no history of virologic trea...
FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir)
IDVYNSO is approved for adults with virologically suppressed HIV-1 with no history of virologic treatment failure and no known substitutions associated with...
Author: Merck.com
Read Original Article